TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 104 filers reported holding TRICIDA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $4,483,000 | -55.1% | 203,792 | -23.0% | 0.15% | -43.4% |
Q4 2019 | $9,984,000 | +24.1% | 264,534 | +1.6% | 0.26% | +1.1% |
Q3 2019 | $8,042,000 | -40.4% | 260,496 | -23.8% | 0.26% | -37.9% |
Q2 2019 | $13,482,000 | +29.1% | 341,672 | +26.4% | 0.42% | +7.7% |
Q1 2019 | $10,441,000 | +104.6% | 270,364 | +24.9% | 0.39% | +79.8% |
Q4 2018 | $5,102,000 | -29.8% | 216,380 | -9.1% | 0.22% | -2.7% |
Q3 2018 | $7,271,000 | -34.1% | 237,995 | -35.5% | 0.22% | -39.9% |
Q2 2018 | $11,034,000 | – | 369,021 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |